Nat Gas Is Going to $5
Health Care: Drugs
NPS Pharmaceuticals Inc (NPSP: NASDAQ)
$14.95 0.42 | 2.89%
05/22/13 - 04:00 PM ET
Portfolios with NPSP
- Portfolio NameUser Type
- UserMy Watch List
- UserJaq Le Blanc 09/30
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorDrugs Facing FDA Approval i...
- ContributorStocks Under-$10 Moving Hig...
- Userchinahound2
- ContributorBreakout Stocks Of The Week...
- Usersalvatore Portfolio 1
- UserRocket Stocks for the week ...
Latest NPSP Headlines from TheStreet
- NPS Pharmaceuticals Inc Stock Upgraded (NPSP) 05.14.13 | 05:05 am
- Cramer's Top Stock Picks: WM VRTX SRPT NPSP DR 04.03.13 | 06:04 am
- Cramer's 'Mad Money' Recap: The Winning Formula 04.02.13 | 08:04 pm
- Mad Money Uncovered: Orphan Drug Stocks
03.20.13 | 12:03 pm - Cramer's Top Stock Picks: HTZ NPSP GLD 03.20.13 | 06:03 am
- Cramer's 'Mad Money' Recap: Be an Informed Skeptic 03.19.13 | 08:03 pm
- Tuesday Trend Continues: Morning Movers 03.19.13 | 10:03 am
- Morning Briefing: 10 Things You Should Know 03.19.13 | 05:03 am
- NPS Pharma Buys Back Worldwide Rights To Short Bowel Syndrome Drug 03.19.13 | 02:03 am
- Biotech Stock Mailbag: Peregrine, Arena, Dendreon, NPS Pharma 01.18.13 | 08:01 am
Press Releases for NPSP
- NPS Pharmaceuticals And Takeda Revise Agreements And NPS Re-Gains Full Worldwide Rights To Teduglutide And Recombinant Human Parathyroid Hormone 1-84 - Business Wire 03.19.13 | 02:03 am
- NPS Pharmaceuticals To Present At Barclays Capital Global Healthcare Conference - Business Wire 03.05.13 | 08:03 am
- NPS Pharmaceuticals Observes Rare Disease Day 2013 And Celebrates 30th Anniversary Of National Organization For Rare Disorders - Business Wire 02.28.13 | 08:02 am
- NPS Pharmaceuticals Reports 2012 Financial Results And 2013 Guidance - Business Wire 02.21.13 | 04:02 pm
- NPS Pharmaceuticals To Present At RBC Capital Markets Healthcare Conference - Business Wire 02.19.13 | 04:02 pm
- NPS Pharmaceuticals To Report 2012 Financial Results - Business Wire 02.13.13 | 08:02 am
- NPS Pharmaceuticals To Present At Upcoming Conferences - Business Wire 02.05.13 | 04:02 pm
- New Peer-reviewed Publication Offers Guidance For Integrating Gattex® (Teduglutide [rDNA Origin]) For Injection Into Management Of Short Bowel Syndrome - Business Wire 01.30.13 | 08:01 am
- NPS Pharmaceuticals To Present At J.P. Morgan Healthcare Conference - Business Wire 01.03.13 | 08:01 am
- NPS Pharmaceuticals To Host Conference Call To Discuss FDA Approval Of Gattex® (teduglutide [rDNA Origin]) For Injection For The Treatment Of Adult Short Bowel Syndrome - Business Wire 01.02.13 | 08:01 am
Partner Headlines for NPSP
- Mid-Afternoon Market Update: MannKind Posts Huge Rally as Markets Plummet - Benzinga 05.22.13 | 04:05 pm
- Current Prime Pharma Entries In Anticipation Of Prime Time Exits - Seeking Alpha 11.06.12 | 09:11 am
- Benzinga Mid-Day Market Update - Benzinga 10.16.12 | 01:10 pm
- 3 Best Biotech Stocks For This Week (Part VI) - Seeking Alpha 10.16.12 | 08:10 am
- NPS Pharmaceuticals: Buy If There Is A Dip - Seeking Alpha 10.14.12 | 08:10 am
- UPDATE: Morgan Stanley Initiates NPS Pharmaceuticals at Overweight on Portfolio Quality - Benzinga 10.04.12 | 01:10 pm
- NPS Pharma Says Gattex Meeting October 16th - Benzinga 08.21.12 | 08:08 am
- 7 High-Growth Small-Cap Stocks With Strong Buy Ratings - Seeking Alpha 07.28.12 | 09:07 am
- Amylin Pharmaceutical POPS 8.9% with 4 Stocks Hitting 52-Week Highs - Wall St. Cheat Sheet 07.03.12 | 10:07 am
- 10 Biotech Stocks With Strong Corporate Governance - Seeking Alpha 01.18.12 | 09:01 am
